Business Segments · Operating Income Loss Margin
Waters Biosciences — Operating Income Loss Margin
This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
StatementSegment
CategoryProfitability
SignalHigher is better
VolatilityModerate
First reportedQ1 2025
Last reportedQ1 2026
How to read this metric
An increase indicates improved operational efficiency or better pricing power within the segment, while a decrease suggests rising costs or margin pressure. It reflects the segment's ability to manage its cost structure relative to its revenue growth.
Detailed definition
This metric represents the operating profitability of the Waters Biosciences business segment, calculated as operating i...
Peer comparison
Comparable to segment-level operating margins reported by life sciences and analytical instrument peers, though variations exist based on product mix and R&D intensity.
Metric ID:
wat_segment_waters_biosciences_operating_income_loss_marginHistorical Data
2 periods
| Q1 '25 | Q1 '26 | |
|---|---|---|
| Value | 0% | 35.8% |
Range0% – 35.8%
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Waters Corporation's waters biosciences — operating income loss margin?
- Waters Corporation (WAT) reported waters biosciences — operating income loss margin of 35.8% in Q1 2026.
- What does waters biosciences — operating income loss margin mean?
- The percentage of revenue that remains as operating profit after covering the costs of running the Waters Biosciences business segment.